Login / Register for free to get access to My MedWorm
MedWorm: Current Discussions on Medical News and Literature RSS FeedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. subscribe with Google ReaderSubscribe to this data using GoogleReader. subscribe with BloglinesSubscribe to this data using Bloglines. subscribe to this feed to follow all MedWorm discussions

Subject: NanoLogix Inc.: NanoLogix Files International Patent Applications, Reclaims 18 Existing Patents, Noted in Department of Defense Quarterly Publication and Provides Operations Update

Subject:

NanoLogix Inc.: NanoLogix Files International Patent Applications, Reclaims 18 Existing Patents, Noted in Department of Defense Quarterly Publication and Provides Operations Updateemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
HUBBARD, OH (MARKET WIRE) NanoLogix, Inc. (PINKSHEETS: NNLX) announces that the company has recently filed BNP™ (BioNanoPore) national patent applications in China, Japan, India, Brazil, Russia and the EU. These applications were filed in order to obtain intellectual property protection for the company's technology in countries viewed as representing the largest potential international market for BNP rapid detection, a revolutionary sandwiched-membrane Petri-based technology that can reduce microorganism detection times by 100-400%.
Source: Market Wire - Pharmaceuticals and Biotech - November 3, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare NNLX Source Type: news

Discussion:

MedWorm Notice: Any discussion posted on this page does not represent MedWorm's opinion. MedWorm does not publish its own articles but provides a means of distribution for publishers and it does not express any opinion or give advice, but provides a forum for free discussion for its website visitors. Please always consult your own doctor before following any course of medical treatment.

You can start a discussion on this item by clicking on the Add Comment button.